Lift BiosciencesLift Biosciences
Lift Biosciences

Lift Biosciences

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Website
2019Active22
Advertise here

About

LIfT BioSciences is a UK-based biotechnology company developing first-in-class, off-the-shelf neutrophil-lineage cell therapies called Immunomodulatory Alpha Neutrophils (IMANs). These therapies are designed to directly kill tumor cells and re-ignite anti-tumor immunity in cancer patients with solid tumors. LIfT BioSciences is preparing for its first-in-human clinical study to assess IMANs' safety and efficacy in patients with advanced cervical and head & neck cancers.

Technology stack

detected 2026-06-19
Est. monthly stack spend~$290/mo
EmailMicrosoft 365
Stack
Wix
Observability
Sentry
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Lift Biosciences do?

LIfT BioSciences is a UK-based biotechnology company developing first-in-class, off-the-shelf neutrophil-lineage cell therapies called Immunomodulatory Alpha Neutrophils (IMANs). These therapies are designed to directly kill tumor cells and re-ignite anti-tumor immunity in cancer patients with solid tumors. LIfT BioSciences is preparing for its first-in-human clinical study to assess IMANs' safety and efficacy in patients with advanced cervical and head & neck cancers.

How much funding has Lift Biosciences raised?

Lift Biosciences has raised a total of $18M in funding.

Where is Lift Biosciences headquartered?

Lift Biosciences is headquartered in Cambridge, United Kingdom.

When was Lift Biosciences founded?

Lift Biosciences was founded in 2019.

What industry does Lift Biosciences operate in?

Lift Biosciences operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Cell Therapy.

How many employees does Lift Biosciences have?

Lift Biosciences has approximately 22 people on record.